Mohammad Althubiti

1.3k total citations
33 papers, 931 citations indexed

About

Mohammad Althubiti is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Mohammad Althubiti has authored 33 papers receiving a total of 931 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Genetics. Recurrent topics in Mohammad Althubiti's work include Cancer-related Molecular Pathways (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Advanced biosensing and bioanalysis techniques (4 papers). Mohammad Althubiti is often cited by papers focused on Cancer-related Molecular Pathways (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Advanced biosensing and bioanalysis techniques (4 papers). Mohammad Althubiti collaborates with scholars based in Saudi Arabia, Egypt and United Kingdom. Mohammad Althubiti's co-authors include Mahmoud Zaki El-Readi, Salvador Macip, Nickolai A. Barlev, Safaa Yehia Eid, Susan Giblett, Alexey V. Antonov, Larissa Lezina, Catrin Pritchard, Gerald Saldanha and Kelvin Cain and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Mohammad Althubiti

32 papers receiving 923 citations

Peers

Mohammad Althubiti
Jie Lan China
Mohammad Althubiti
Citations per year, relative to Mohammad Althubiti Mohammad Althubiti (= 1×) peers Jie Lan

Countries citing papers authored by Mohammad Althubiti

Since Specialization
Citations

This map shows the geographic impact of Mohammad Althubiti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Althubiti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Althubiti more than expected).

Fields of papers citing papers by Mohammad Althubiti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammad Althubiti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Althubiti. The network helps show where Mohammad Althubiti may publish in the future.

Co-authorship network of co-authors of Mohammad Althubiti

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammad Althubiti. A scholar is included among the top collaborators of Mohammad Althubiti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammad Althubiti. Mohammad Althubiti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
El-Readi, Mahmoud Zaki, Mohammad Althubiti, Nahla Ayoub, et al.. (2023). Liver Injury in Favipiravir-Treated COVID-19 Patients: Retrospective Single-Center Cohort Study. Tropical Medicine and Infectious Disease. 8(2). 129–129. 2 indexed citations
3.
El-Readi, Mahmoud Zaki, Bassem Refaat, Riyad A. Almaimani, et al.. (2023). Antioxidative and Anti-Inflammatory Protective Effects of Fucoxanthin against Paracetamol-Induced Hepatotoxicity in Rats. Marine Drugs. 21(11). 592–592. 9 indexed citations
4.
Elsayed, Ibrahim, Jihan Hussein, Mohammad Althubiti, et al.. (2023). Development of Transdermal Oleogel Containing Olmesartan Medoxomil: Statistical Optimization and Pharmacological Evaluation. Pharmaceutics. 15(4). 1083–1083. 6 indexed citations
6.
Althubiti, Mohammad. (2022). β2-microglobulin is overexpressed in buccal cells of elderly and correlated with expression of p16 and inflammatory genes. Saudi Journal of Biological Sciences. 29(10). 103418–103418. 2 indexed citations
7.
Nasif, Wesam A., et al.. (2022). Emphasizing the link between blood types in multi-ethnic disparities and COVID-19 infection in Makkah, Saudi Arabia. Saudi Medical Journal. 43(2). 177–186. 5 indexed citations
8.
El-Readi, Mahmoud Zaki, Ahmed M. Al‐Abd, Mohammad Althubiti, et al.. (2021). Multiple Molecular Mechanisms to Overcome Multidrug Resistance in Cancer by Natural Secondary Metabolites. Frontiers in Pharmacology. 12. 658513–658513. 33 indexed citations
9.
Althubiti, Mohammad, et al.. (2021). Beta 2 microglobulin correlates with oxidative stress in elderly. Experimental Gerontology. 150. 111359–111359. 18 indexed citations
10.
Poblocka, Marta, Victoria M. Smith, Ana Sousa Manso, et al.. (2021). Targeted clearance of senescent cells using an antibody-drug conjugate against a specific membrane marker. Scientific Reports. 11(1). 20358–20358. 99 indexed citations
11.
Althubiti, Mohammad, Riyad A. Almaimani, Safaa Yehia Eid, et al.. (2020). BTK targeting suppresses inflammatory genes and ameliorates insulin resistance. European Cytokine Network. 31(4). 168–179. 8 indexed citations
12.
El-Readi, Mahmoud Zaki, Ahmad A. Mirza, Hiba S. Al-Amodi, et al.. (2020). Evaluation of the Diagnostic and Predicative Values of 8-Iso-Prostaglandin F2α as a Biomarker of Breast Cancer. Oncology Research and Treatment. 43(10). 506–517. 10 indexed citations
13.
El-Readi, Mahmoud Zaki, Mohammad Althubiti, Riyad A. Almaimani, et al.. (2020). Tamoxifen and the PI3K Inhibitor: LY294002 Synergistically Induce Apoptosis and Cell Cycle Arrest in Breast Cancer MCF-7 Cells. Molecules. 25(15). 3355–3355. 28 indexed citations
14.
El-Readi, Mahmoud Zaki & Mohammad Althubiti. (2019). Cancer Nanomedicine: A New Era of Successful Targeted Therapy. Journal of Nanomaterials. 2019. 1–13. 52 indexed citations
15.
El-Readi, Mahmoud Zaki, Mohammad Althubiti, Hala F. M. Kamel, et al.. (2018). 8-Hydroxy-2’-deoxyguanosine as a Discriminatory Biomarker for Early Detection of Breast Cancer. Clinical Breast Cancer. 19(2). e385–e393. 29 indexed citations
16.
Althubiti, Mohammad, et al.. (2018). Trends in the incidence and mortality of cancer in Saudi Arabia. Saudi Medical Journal. 39(12). 1259–1262. 92 indexed citations
17.
Althubiti, Mohammad, Miran Rada, Koon-Guan Lee, et al.. (2016). BTK Modulates p53 Activity to Enhance Apoptotic and Senescent Responses. Cancer Research. 76(18). 5405–5414. 48 indexed citations
18.
Althubiti, Mohammad & Salvador Macip. (2016). Detection of Senescent Cells by Extracellular Markers Using a Flow Cytometry-Based Approach. Methods in molecular biology. 1534. 147–153. 9 indexed citations
19.
Senra, Joana M., I. Acosta-Colman, Mohammad Althubiti, et al.. (2014). The Role of the HIF-1α Transcription Factor in Increased Cell Division at Physiological Oxygen Tensions. PLoS ONE. 9(5). e97938–e97938. 28 indexed citations
20.
Althubiti, Mohammad, Larissa Lezina, Rebekah Jukes‐Jones, et al.. (2014). Characterization of novel markers of senescence and their prognostic potential in cancer. Cell Death and Disease. 5(11). e1528–e1528. 209 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026